Addex Therapeutics Ltd Share Premium
Addex Therapeutics Ltd (ADXN) had Share Premium of CHF 266.94 million as of 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Notes
ifrs-full:SharePremium · last filed 2025-09-30
- 2025-06-30: Share Premium 266.94M CHF.
- 2024-12-31: Share Premium 266.38M CHF.
- 2023-12-31: Share Premium 266.19M CHF.
- 2023-06-30: Share Premium 263.66M CHF.
| Period end | Share Premium |
|---|---|
| 2025-06-30 | 266.94M CHF 6-K · filed 2025-09-30 |
| 2024-12-31 | 266.38M CHF 6-K · filed 2025-09-30 |
| 2023-12-31 | 266.19M CHF 20-F · filed 2025-05-15 |
| 2023-06-30 | 263.66M CHF 6-K/A · filed 2023-12-21 |
| 2022-12-31 | 269.51M CHF 20-F · filed 2024-04-18 |
| 2022-06-30 | 283.72M CHF 6-K/A · filed 2022-09-14 |
| 2021-12-31 | 283.98M CHF 20-F · filed 2023-03-30 |
| 2020-12-31 | 286.89M CHF 20-F · filed 2022-03-10 |
| 2019-12-31 | 286.38M CHF 20-F · filed 2021-03-11 |
| 2018-12-31 | 286.48M CHF 20-F · filed 2020-04-27 |